News >

Surgical and Systemic Techniques Evolving for Melanoma Patients With Brain Mets

Gina Columbus
Published: Thursday, Jul 20, 2017

Douglas Kondziolka, MD

Douglas Kondziolka, MD
Approximately 30% of patients with melanoma will develop brain metastases; however, with the advancements of precise radiosurgery as well as combination systemic therapies, survival outcomes are improving.

State of the Science Summit on Melanoma and Immuno-Oncology.

OncLive: Please discuss the highlights of your presentation on brain metastases.

Kondziolka: Brain metastases are a very common cancer and, unfortunately, [are something] that means a lot for the patient and their family. A patient with cancer, whether it be melanoma or any type of cancer, is battling it and, hopefully, successfully. If they get the news that the cancer is now in the brain or spinal cord, that’s a scary thing. It means it could potentially affect function, who they are, what they are about, their ability to walk, memory, speech, and vision. It means a lot and, often, they are aware of the fact that if the cancer is in the brain, sometimes that affects survival. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Melanoma: Exploring BRAF/MEK in Adjuvant and Neoadjuvant SettingsSep 28, 20191.5
Medical Crossfire®: What Does Data Tell Us About How to Optimize Checkpoint Inhibitor Strategies Across Lines of Care for Patients with Melanoma?Nov 30, 20191.5
Publication Bottom Border
Border Publication
x